Introduction
Receptors for primary agonists in platelets including protease-activated receptors (PARs) mostly belong to the seven transmembrane domain G-protein coupled receptor (GPCR) family. 1 ADP, important both for haemostasis and thrombosis, possesses two platelet receptors belonging to this family. P2Y 1 is coupled to Gq and is responsible for shape change, Ca 2+ mobilization and the initiation of aggregation. 2, 3 The more recently cloned P2Y 12 is coupled to G i2 and is necessary for the formation and stabilization of large aggregates. 4, 5 Apart from platelets, P2Y 1 is present in endothelial cells, skeletal muscle cells and placenta. TP constitutes the major thromboxane-prostanoid receptor on platelets. 6 TP is responsible for shape change, Ca 2+ mobilization, and platelet aggregation. It is associated not only with Gq protein 7 , but also with G 12 and G 13, 8 through which it acts as a modulator of the Na + /H + exchanger. 9 TP is present in thymus, lung, kidney, spleen and placenta. 10, 11 TP is the form that has been preferentially identified in platelets. [12] [13] [14] Although mRNA from the ß-isoform derived from an alternative splicing at the 3 rd exon of the TP gene has been reported in platelets, 12, 13 doubts remain about the presence of TP protein. 14 Both P2Y 1 and TP initiate platelet activation through the PLC pathway. 15 ADP-and TXA 2 -dependent activation pathways are major targets for anti-thrombotic therapy. 16 Both agonists can be released during platelet activation, TXA 2 is produced during arachidonic acid metabolism while ADP is stored in a secretable pool in dense granules.
Many receptors in platelets are found in both surface and intracellular membranes, an example being the IIb ß 3 integrin. 17 For GPIb, an adhesion receptor, platelet activation is followed by its transient internalization. 17 The PAR-1 receptor for thrombin, a GPCR, has been shown to traffic during platelet activation. 18, 19 Desensitization of GPCRs has been suggested to involve both sequestration and/or uncoupling of the receptor from G proteins. 20, 21 Little is known about the localization of ADP and TXA 2 receptors on platelets. In this study, we have combined immunogold labeling on ultrathin cryosections with electron microscopy to evaluate the cellular distribution of P2Y 1 and TP . Similarities were found in the distribution of both receptors: i) labeling was greater inside the platelets than on the plasma membrane, ii) pools were present in membranes ofgranules and those of the open canalicular system (OCS), iii) increased labeling was seen after platelet activation with ADP and TXA 2 , and iv) for each receptor prolonged exposure to agonist returned labeling density to baseline. By using the MoAb, AP-6, which recognizes a ligand-induced binding site (LIBS) on the integrin, 17 we were able to show integrin activation early in secretion. Secreted ADP or newly formed TXA 2 would be likely to come in contact with these receptors prior to the external pool.
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Materials and Methods

Platelet preparations
Peripheral blood was obtained by clean venipuncture from adult human volunteers without medication for at least a week. The initial 3 mL of blood was discarded. Blood was collected into acid-citrate-dextrose NIH formula A (ACD-A) (1 vol of anticoagulant : 6 vol of blood). 5 Platelet-rich plasma (PRP) was prepared by centrifugation at 120 x g for 10 min at room temperature. To prepare washed platelets, 0.05 U/mL apyrase grade VII (Sigma Chemical Company, Saint-Quentin-Fallavier, France) and ACD-A (1 vol to 9 vol PRP) were added immediately to the PRP. Platelets were sedimented by centrifugation at 1200 x g for 15 min and resuspended in 137 mmol/L NaCl, 2 mmol/L KCl, 12 mmol/L NaHCO 3 , 0.3 mmol/L NaH 2 PO 4 , 1 mmol/L MgCl 2 , 5.5 mmol/L glucose, 5 mmol/L Hepes, 0.1 % (wt/vol) bovine serum albumin (BSA, Sigma), and 0.05 U/mL apyrase, pH 7.4
(Hepes-Buffered Modified Tyrode, HBMT). Studies were also performed on platelets from patient (M.L.) with an inherited disease recently linked to the absence of the second platelet ADP receptor, P2Y 12 , 4 Platelets from this patient show a reduced and rapidly reversible aggregation to high doses of ADP. 5 They also show a reduced response to thromboxane analogs. 22 For platelet activation, unstirred suspensions of washed platelets at 2.5 x 10 8 /mL were incubated at 37°C for the stated times with 10 µmol/L ADP (Sigma) or 10 nmol/L I-BOP (Caiman Chemical, Ann Arbor, USA) in the presence or not of 400 µg/mL purified human fibrinogen (Fg) (a gift from Dr. K. Boulimez, Biochemistry Department, Hôpital Cardiologique, Pessac; the Fg was >95% pure as assessed by SDSpolyacrylamide gel electrophoresis). Desensitization was achieved by incubating platelet suspensions with 1 mmol/L ADPßS (Sigma), a stable analog of ADP, for 1h at 37 °C as described by Baurand et al, 23 or with 10 nmol/L I-BOP for 1h at 37°C, again in the absence of stirring.
Megakaryocytes
Bone marrow was taken by sternal puncture performed during a cardiovascular intervention in a hematologically normal patient. Informed consent was obtained. A volume (0.5mL) of bone marrow was delicately added to 5 mL PBS without disruption of the marrow structure. 24 The material was fixed in 1.25 % (vol/vol) glutaraldehyde (Fluka AG, Buchs, Switzerland) in phosphate-buffered saline (PBS) and processed according to our standard procedures, 24 and as for platelets as described below.
Electron microscopy and immunogold labeling
Antibodies. A monoclonal antibody (MoAb) recognizing the P2Y 1 receptor was obtained by immunizing mice against a 16aa peptide corresponding to the N-terminal domain of the receptor coupled to keyhole limpet hemocyanin. 25 It was used as purified IgG. The polyclonal antibody to TP was raised in rabbits against a peptide composed of 15aa (327-341) located at the end of the carboxyl-terminal tail which corresponds to a specific sequence of TP which differs from that of TP . 26 The immunoglobulin fraction was isolated using the E-Z-SEPkit (Amersham Pharmacia) and its specificity shown. 26 dilution of the polyclonal antibody to TP in PBS-1% alb and then with a goat anti-rabbit antibody adsorbed onto 10 nm gold particles as described above. The anti-LIBS MoAb, AP-6, was used at a dilution of 1/10000 and its binding assessed using an anti-IgM antibody associated with gold particles (1/100 dilution of AuroProbe EM GAM IgM G10; Amersham, Les Ulis, France). In double staining, the anti-P-selectin used corresponded to a mixture of 3 MoAbs (VH10, 2.5 µg/ml; S12, 2.5 µg/ml; AK6 1 µg/ml) as described previously. 27 P-selectin was detected using AuroProbe EM GAM G5.
Controls included the absence of primary antibody or its substitution with an irrelevant IgG or IgM of the same species and at the same concentration. The MoAb anti-CD56 (Dako S.A., Trappes, France) was used instead of P2Y 1 at the same concentration, and isolated IgG of a rabbit antibody directed against S100 protein (Dako S.A., Trappes, France) was used instead of the anti-TP . We also performed blocking experiments by preincubating the P2Y 1 MoAb with 200 µg/mL of the peptide used for the immunization and likewise the rabbit antibody with 50 µg/mL of the peptide used for immunization as described by Habib et al. 26 The mixtures were then incubated with the sections on the grids as described above.
Electron microscopy and quantitative analyses. The grids were floated several times on PBS and then on water. The cryosections were stained by uranyl acetate and osmium according to our standard procedures and embedded in a thin film of methylcellulose prior to observation with a Jeol JEM-1010 transmission electron microscope (Jeol, Croissy-sur-seine, France) at 80 KV. 24 For quantitative analyses of immunogold labeling, the mean surface area of each platelet section was calculated for at least 50 sections using the Metamorph software Universal Imaging, Paris, France) and a Pentium III computer. 24 The gold particles were counted visually for each platelet section. The results are expressed as mean values ± SD for a minimum of 50 sections. Statistical analysis was performed using the Student's t-test.
Flow cytometry
Unstimulated platelets or those activated with 10 µmmol/L ADP for 10 min were fixed in 1% (wt/vol) paraformaldehyde (PFA) as described previously. 27 To permit access to the internal compartment, platelets were
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 6 treated with 0.1% (vol/vol) Triton X-100 for 30 min, washed, and then incubated overnight at 4°C with the anti-P2Y 1 MoAb (10 µg/mL). After further washing, platelets were incubated with phycoerythrin (PE)-labeled F(ab') 2 fragments of a sheep anti-mouse IgG (Silenus Laboratories Ltd, Hawthorn, Australia). Negative controls were performed in the presence of 10 µg/ml of a MoAb to CD56 instead of P2Y 1 . Samples were analyzed FACScan (Becton Dickinson, SA, Le Pont de Claix, France). Gating to select the majority of platelets was based on preliminary determinations of forward and wide-angle light scatter. Fluorescence was measured after passage through a 530 nm long pass interference filter. Histograms were generated from measurements of 10,000 cells and data were analyzed using the LYSYS II software of the FACScan system.
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Results
Immunolocalisation of P2Y 1
Resting platelets. We first examined the distribution of P2Y 1 within the membrane systems of unstimulated platelets. Using a single MoAb, an amplification procedure involving successive incubations with a FITClabeled anti-mouse IgG and a polyclonal antibody to FITC proved necessary for optimal visualization of the receptor. Labeling of ultrathin sections showed a majority of gold particles localized to membrane systems within the interior of the cells although surface labeling was observed (Fig 1a) . Note the typical discoid shape of this unstimulated platelet. Details of intracellular structures containing P2Y 1 are illustrated in Fig 1 (b-d) . Gold particles were associated with thin channels (panel b). Previously, we have reported that these can link the platelet surface to the granules and may represent routes of trafficking for proteins and receptors (see ref 27 and Discussion). Labeling was also observed in more dilated elements of the OCS as shown in panel (c). Finally, there was occasional labeling of the membranes of -granules. There was no labeling of multivesicular bodies sometimes observed in -granules 28 and clearly visible in the granule to the right of panel (d).
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Homologous desensitization experiments were performed at 37°C by incubating platelets without stirring with 1mmol/L ADP S, chosen because of its stability (see 23 ). Platelet function testing showed that platelets initially aggregated with ADP S when stirred, while electron microscopy and immunogold labeling showed similar changes at 10 min of unstirred incubation to those seen with native ADP (not illustrated).
However, after incubation with ADP S for 1h the platelets were unable to aggregate even to freshly added 10 µmol/L ADP and were desensitized. Immunogold labeling of ultrathin sections showed that these platelets now had a discoid shape and that the distribution of P2Y 1 within the different membrane systems was similar to that of unstimulated platelets.
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Results confirmed that approximately fivefold more gold particles were associated with membrane pools inside the platelet than with the platelet surface. On sections of platelets activated by ADP, the density of gold particles increased both at the platelet surface (p < 0.001) and also in the internal membrane systems (p < 0.02). At the same time there was an increase in surface area (p < 0.02). The values for desensitized platelets were close to those obtained for unstimulated platelets for both the surface and the internal compartment. The surface area also returned to values close to those of unstimulated platelets.
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Flow cytometry analysis of P2Y 1
Flow cytometry was used as a second approach to confirming the presence of internal pools of P2Y 1 . Histograms corresponding to the binding of the anti-P2Y 1 MoAb to the surface of PFA-fixed unstimulated platelets showed weak labeling (Fig. 4 panel A) , confirming previous results. 25 A slight increase in mean fluorescence intensity (MFI) was observed after ADP stimulation. A clearly increased MFI for permeabilized platelets with Triton X-100 showed an internal pool, thus agreeing with the results found by electron microscopy and the semiquantitative analysis (panel B).
For Platelets were also incubated with I-BOP, a stable analog of TXA 2 for 10 min without stirring. The morphology of the now activated platelet resembled that of ADP-treated platelets with a rounded shape, centralization of granules and the presence of pseudopods. Labeling was again not only increased on the surface, but was also greater in the internal pools (Fig. 6 ).
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Table 2 ). Furthermore, preincubation of the antibody to TP with blocking amounts of the peptide used for immunization also resulted in a loss of the labeling highlighted above (not illustrated). Table 2 show that for this antibody between three-to fourfold more gold particles were associated with the internal membrane pools than with the platelet surface. The total number of gold particles increased significantly for both the surface membrane (p < 0.001) and the internal pool (p < 0.001) after I-BOP treatment. The surface area of the platelets also increased significantly (p < 0.001). All values returned to initial levels after desensitization. For the patient (M.L.), I-BOP stimulation also induced a significantly greater antibody labeling (p < 0.001), for both the surface and the internal compartment. In contrast, the increase in surface area was not significant (p > 0.05).
Semi-quantitative analyses. Results in
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Intraplatelet activation of IIb ß 3 associated with secretion Since receptors for two primary agonists have been
revealed to be associated with thin channels and -granule membranes, we looked closely at the activation of internal pools of IIb ß 3 using a MoAb, AP-6, recognizing this integrin after Fg has bound. In agreement with our initial report, 27 with unstimulated platelets occasional labeling with AP-6 is mostly confined to the -granule membrane (Fig 7, panel a This was also confirmed by performing experiments in the absence of added Fg (not shown).
Fig 7 Detection of activated IIb ß 3 by the anti-LIBS MoAb, AP-6.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Immunogold labeling of P2Y 1 and TP in megakaryocytes We finally looked to see how P2Y 1 and TP were distributed in mature human MK obtained from a control donor. MK were identified in a marrow aspirate by their typical morphology and the presence of a polylobular nucleus. 24 Labeling was detected on surface membranes, but was relatively sparse (not illustrated). Significantly, both P2Y 1 and TP were present along the demarcation membrane system (DMS). Both receptors were also detected in membranes of granules (Fig 7) . Thus both P2Y 1 and TP are expressed during megakaryocyte maturation and are therefore likely to be present in the different membrane systems of platelets at the time of their release. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From
Discussion
We have compared the distribution within the platelet of two receptors, P2Y 1 and TP belonging to the GPCR family. Although many members of this family have been identified in platelets, apart from PAR-1, a receptor for thrombin, 1, 18, 19 little is known about their distribution within the different membrane systems. As well as having a plasma membrane, platelets have a well-developed OCS and several types of storage organelle. Major changes are seen in the distribution of these membranes during platelet activation and secretion (reviewed in 17 ).
Interestingly, although P2Y 1 and TP were found as expected in the plasma membrane, the bulk of the immunogold labeling on ultrathin sections concerned internal membrane pools. These included the membranes of -granules and those of the OCS, including an important network of thin channels that ramify from the surface into the interior of the platelet. The presence of major intracellular pools of these receptors for primary agonists in platelets can have important implications for platelet physiology.
P2Y 1 and TP are both associated with G proteins and generate signals inducing platelet activation.
3,7-9,15 ADP is the specific ligand for P2Y 1 in platelets. ADP also has a second receptor, P2Y 12 , only recently cloned. 4, 29 The sparse labeling observed at the platelet surface with the anti-P2Y 1 MoAb is in accordance with the low binding previously observed with the same antibody in flow cytometry 25 and also confirmed here. ADP receptors have been quantified using radiolabeled 2MeS-ADP, which binds to between 500 and 1000 sites per platelet. 5, [30] [31] [32] This stable ADP analog binds to both P2Y 1 and P2Y 12 . Evaluation of the specific contribution of P2Y 1 is allowed by binding studies performed under conditions where one receptor is blocked or absent. In the two well-characterized patients lacking P2Y 12 , the number of 2MeS-ADP binding sites fell to about 30 for patient (M.L.) 5 and to about 170 for a second patient. 30 This low range of values explains why an amplification procedure was required to detect P2Y 1 using the single MoAb available to us. Since it is unlikely that 2MeS-ADP can reach all of the internal receptor pools identified by us, the number of sites found using radiolabeled ligand almost certainly underestimates the total number of copies per platelet. Intriguingly, in the SP1999 mouse model where P2Y 12 was deleted, no specific binding with 2MeS-ADP could be measured. 29 Since our results for patient (M.L.) show a relatively normal distribution of P2Y 1 between the surface and internal pools, the hypothesis of a downregulation of P2Y 1 in the absence of P2Y 12 can be excluded, at least in man. Surprisingly, the surface area of platelets increased less for the patient than for the controls during ADP activation suggesting that although shape change is present, and pseudopods form, an associated volume change is absent.
When using a rabbit antibody to the carboxyl-domain of TP , sufficient labeling was obtained for a classic detection procedure to be used. Yet, labeling of the surface membrane again remained sparse. Once more, greater numbers of gold particles were seen inside platelets, with the membranes of -granules and those of the thin channels of the OCS again labeled. Previous binding studies with radiolabeled I-BOP, showed close to 1500 sites of TP per platelet. 33, 34 I-BOP binds to both high and low affinity sites. With doubts expressed over the presence of TPß, it was suggested that TP can represent the two affinity states recognized by TXA 2 mimetics in platelets. 26 It is probable that our MoAb recognizes both forms. As P2Y 1 and TP show a similar distribution in the different membrane systems of the platelet, it will be interesting to extend these studies to other GPCR receptors, and particularly to P2Y 12 , to see if this is a common finding. Platelets from patient (M.L.) have a much decreased aggregation response to I-BOP. 22 This was interpreted as showing that ADP (via P2Y 12 ) was a major
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After platelet activation, the labeling of P2Y 1 and TP significantly increased both at the platelet surface and also inside the cell although this increase was lower. Since the capacity for protein synthesis in platelets is very low, an explanation is that their reactivity and/or accessibility to the antibodies on the platelet sections is increased. Trafficking of receptors from the internal pool to the periphery of the cell may also contribute. Interestingly, desensitization was accompanied by a return to a discoid shape and basal surface area of platelets and reactivity with the antibodies on platelet sections, which is in favor of a reversible change in receptor accessibility and/or conformation associated with activation. Another GPCR, the 2 -adrenergic receptor, is known to modify its conformation after stimulation through removal of a constraint imposed by an ionic lock located in internal cytoplasmic domains. 35 Events such as this could potentially influence the binding of antibodies.
Baurand et al 23 A major question purports to the possible functional significance of the internal pools, present not only on the membranes of the OCS and thin channels, but also in the membrane of the -granules. Platelets possess a storage pool of ADP within the dense granules. This pool is secreted into the channels of the OCS before being released to the external medium. 37 TXA 2 is produced in platelets following arachidonic acid release and activation of the prostaglandin synthesis pathway. 38 Liberation of arachidonic acid from membrane phospholipids can be induced by many agonists including ADP and collagen. 38, 39 It can be hypothesized that during the activation that follows platelet attachment to subendothelial constituents such as collagen or vWF, the internal pools of receptors for primary agonist would be in contact with TXA 2 before their homologues present at the platelet surface. Similarly, ADP released from the granules can have access to P2Y 1 receptors inside the platelet before the external pool. Using a mathematical model, Fogelson and Wang, 40 have shown that following diffusion of ADP through the channels, the near-surface concentration is very low compared to the internal concentration. In -storage pool disease (SPD), where ADP is absent or severely decreased in dense granules, 41 or in aspirin-treated platelets where TXA 2 cannot be formed, 38 no second wave of aggregation is seen after activation by ADP while collagen-induced platelet activation is also much reduced. The ability of ADP to induce secretion from platelets is controversial, 42 and may depend on the presence or not of Ca 2+ in the medium.
Notwithstanding, incubation of platelets with ADP in our studies resulted in an increased amount of ligandbound IIb 3 on -granule membranes and in associated thin channels presumably representing initiation of secretory pathways for they contained P-selectin. The extent of the changes was nonetheless very different from
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From the maximal secretion that occurred after activation of platelets with thrombin, where Fg associates rapidly with internal pools of IIb ß 3. prior to being translocated to the exterior 27 Definitive proof for a functional role of the intracellular receptors is not easy to obtain. Pharmacological inhibitors of ADP receptors such as A3P5P (P2Y 1 ) and AR-C69931MX (P2Y 12 ) or ADP eliminating enzymes such as CP/CPK, while blocking surface receptors and removing extracellular ADP, would enter the OCS to unknown extents. Thrombus build up on collagen under flow was markedly affected by a combination of A3P5P and AR-C69931MX with both adhesion and platelet to platelet interactions affected. 43 Yet, addition of CP/CPK with total ADP removal was more complete, leaving open a partial inhibition of receptors in the OCS by the antagonists. Similarly, we have shown that a combination of A3P5P, AR-C69931MX and CP/CPK leads to a more effective inhibition of TRAP-induced platelet aggregation than the individual antagonists alone or in pairs perhaps suggesting that total inhibition of the receptor pools is difficult to achieve (P. Nurden, unpublished data).
In summary, we have observed that platelets possess in addition to the plasma membrane pool of receptors for primary agonists, ADP and TXA 2 , an internal pool present in membranes of -granules and in a network of channels connected to the surface membrane, with in proximity integrin effectors and ligands. These constitute a microenvironment that becomes interlinked when exocytosis occurs. A subcellular localization ofsubunits of trimeric G-proteins to -granule membranes has been previously shown, 44 so another important part of the signaling machinery is also in place for agonists that could act alone or in synergy. 45 Our results therefore raise the question of the role of this internal compartment of agonist receptors and its contribution in platelet activation. At the present time, ADP receptors are a major target for antithrombotic therapy as is TP . For personal use only. on September 14, 2017. by guest www.bloodjournal.org From
